| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.002 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |